Literature DB >> 12225749

The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators.

John R Somoza1, James T Palmer, Joseph D Ho.   

Abstract

Cathepsin F is a lysosomal cysteine protease of the papain family, and likely plays a regulatory role in processing the invariant chain that is associated with the major histocompatibility complex (MHC) class II. Evidence suggests that inhibiting cathepsin F activity will block MHC class II processing in macrophages. Consequently, inhibitors of this enzyme may be useful in treating certain diseases that involve an inappropriate or excessive immune response. We have determined the 1.7A structure of the mature domain of human cathepsin F associated with an irreversible vinyl sulfone inhibitor. This structure provides a basis for understanding cathepsin F's substrate specificity, and suggests ways of identifying potent and selective inhibitors of this enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225749     DOI: 10.1016/s0022-2836(02)00780-5

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.

Authors:  Katherine R Smith; Hans-Henrik M Dahl; Laura Canafoglia; Eva Andermann; John Damiano; Michela Morbin; Amalia C Bruni; Giorgio Giaccone; Patrick Cossette; Paul Saftig; Joachim Grötzinger; Michael Schwake; Frederick Andermann; John F Staropoli; Katherine B Sims; Sara E Mole; Silvana Franceschetti; Noreen A Alexander; Jonathan D Cooper; Harold A Chapman; Stirling Carpenter; Samuel F Berkovic; Melanie Bahlo
Journal:  Hum Mol Genet       Date:  2013-01-07       Impact factor: 6.150

2.  A Novel Yeast Surface Display Method for Large-Scale Screen Inhibitors of Sortase A.

Authors:  Lin Wu; Huijun Li; Tianle Tang
Journal:  Bioengineering (Basel)       Date:  2017-01-24

3.  A proteomic analysis of serum-derived exosomes in rheumatoid arthritis.

Authors:  Hirotaka Tsuno; Mitsumi Arito; Naoya Suematsu; Toshiyuki Sato; Atsushi Hashimoto; Toshihiro Matsui; Kazuki Omoteyama; Masaaki Sato; Kazuki Okamoto; Shigeto Tohma; Manae S Kurokawa; Tomohiro Kato
Journal:  BMC Rheumatol       Date:  2018-11-27

4.  Processing and Maturation of Cathepsin C Zymogen: A Biochemical and Molecular Modeling Analysis.

Authors:  Anne-Sophie Lamort; Yveline Hamon; Cezary Czaplewski; Artur Gieldon; Seda Seren; Laurent Coquet; Fabien Lecaille; Adam Lesner; Gilles Lalmanach; Francis Gauthier; Dieter Jenne; Brice Korkmaz
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

Review 5.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12

6.  Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment.

Authors:  Liyuan Song; Xianhui Wang; Wang Cheng; Yi Wu; Min Liu; Ruizi Liu; Shenyi Zhang; Hong Xia; Hao Liu; Xuejiao Tai; Huzi Zhao; Xihua Li; Fuyun Ji
Journal:  BMC Pulm Med       Date:  2021-12-20       Impact factor: 3.317

7.  Cathepsin F cysteine protease of the human liver fluke, Opisthorchis viverrini.

Authors:  Porntip Pinlaor; Natthawut Kaewpitoon; Thewarach Laha; Banchob Sripa; Sasithorn Kaewkes; Maria E Morales; Victoria H Mann; Sandi K Parriott; Sutas Suttiprapa; Mark W Robinson; Joyce To; John P Dalton; Alex Loukas; Paul J Brindley
Journal:  PLoS Negl Trop Dis       Date:  2009-03-24

Review 8.  SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells.

Authors:  Rolando Cannalire; Irina Stefanelli; Carmen Cerchia; Andrea R Beccari; Sveva Pelliccia; Vincenzo Summa
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.